Sequence determinants of innate immune activation by short interfering RNAs.
about
siRNA Versus miRNA as Therapeutics for Gene SilencingCytokines as biomarkers of nanoparticle immunotoxicitySequence-non-specific effects of RNA interference triggers and microRNA regulators.Rational design of immunostimulatory siRNAs.Differential induction of interleukin-10 in monocytes by HIV-1 clade B and clade C Tat proteins.A status report on RNAi therapeutics.An overview on the field of micro- and nanotechnologies for synthetic Peptide-based vaccinesAnti-tumor efficacy of naked siRNAs for ERBB3 or AKT2 against lung adenocarcinoma cell xenografts.Transcriptional gene silencing of HIV-1 through promoter targeted RNA is highly specific.In vivo screening of modified siRNAs for non-specific antiviral effect in a small fish model: number and localization in the strands are importantDevelopment of Therapeutic-Grade Small Interfering RNAs by Chemical Engineering.Short-interference RNAs: becoming medicines.Pharmacological Characterization of a Novel ENaCα siRNA (GSK2225745) With Potential for the Treatment of Cystic FibrosisDesign of siRNA Therapeutics from the Molecular ScaleSubcellular fate and off-target effects of siRNA, shRNA, and miRNA.siRNA and cancer immunotherapy.Prediction of Immunomodulatory potential of an RNA sequence for designing non-toxic siRNAs and RNA-based vaccine adjuvants.Imaging-guided delivery of RNAi for anticancer treatment.Toll-like receptor 7/8 agonist resiquimod induces late preconditioning in neonatal cardiac myocytes.Computational Prediction of the Immunomodulatory Potential of RNA Sequences.RNAi nanoparticles in the service of personalized medicine.Transforming growth factor β1 (TGFβ1) regulates CD44V6 expression and activity through extracellular signal-regulated kinase (ERK)-induced EGR1 in pulmonary fibrogenic fibroblasts.
P2860
Q26786876-09933B0D-8134-4CE6-A4CD-DA8A460A9803Q28383550-108A9282-E35E-4175-B625-F1B86207E5BBQ33566425-B1925D02-30A0-4D81-AFA0-50CCA785C96EQ33822185-85C58480-D318-4CF4-B892-ED1A7F9E4D44Q33897742-592F18F6-3C2B-4B7C-B870-3C08B181257FQ34013891-C4BE20B6-4E2D-4804-A8FD-A1D524A86613Q35100779-CAFEAE68-FCFD-4634-B1FA-9055784944AAQ35563891-8F703406-C717-442D-BD80-CDB8985EC6AFQ35667591-515B6FB8-E61A-4B41-82EB-CE64A2114429Q36044790-4CB23192-5643-4DD2-87B4-361F99B07A5BQ36174842-A2699390-33B2-455D-8641-D8167F5D1A93Q36347546-71FD0333-B28B-4300-94DF-0A7F0D1E0201Q36587576-30351738-CEFA-4E07-AA8E-99DC013FECAFQ37111734-88C3A62C-992C-407C-A963-F1B1A2171A21Q37950261-3F0E6C6E-0A9A-4CDF-A7D3-87B74F0498F1Q38050504-FBF5D8DF-48ED-47AA-861D-D79CC227ED34Q38333686-A0FA5B02-EF00-4C53-A610-19E2ADED4A51Q38710046-57F5711F-E975-41E1-81A7-BDDBFFAF0170Q39014895-9E1445AB-8C22-4C0B-80B5-46D9EC508FDBQ45946589-E325EF49-CA37-4AD2-8EB6-6DE38B95D3B4Q47587577-63521D9D-4254-48AC-B68D-4BB2D2395E9CQ50925712-F581D01D-BA39-4D99-916E-443F2BF49206
P2860
Sequence determinants of innate immune activation by short interfering RNAs.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Sequence determinants of innate immune activation by short interfering RNAs.
@ast
Sequence determinants of innate immune activation by short interfering RNAs.
@en
type
label
Sequence determinants of innate immune activation by short interfering RNAs.
@ast
Sequence determinants of innate immune activation by short interfering RNAs.
@en
prefLabel
Sequence determinants of innate immune activation by short interfering RNAs.
@ast
Sequence determinants of innate immune activation by short interfering RNAs.
@en
P2093
P2860
P50
P356
P1433
P1476
Sequence determinants of innate immune activation by short interfering RNAs
@en
P2093
Amber Goodchild
Greg M Arndt
Marcel Tanudji
Nicole Nopper
P2860
P2888
P356
10.1186/1471-2172-10-40
P577
2009-07-24T00:00:00Z
P5875
P6179
1042441804